Lumida
/CRSP
⌘K
CRISPR Therapeutics AG

CRISPR Therapeutics AG

CRSP
$47.78USD-1.63%-0.79 today

MARKET CAP

4.6B

P/E (TTM)

FWD P/E

DAY RANGE

$47 – $49

52W RANGE

$44
$78

AI Summary

Stalk
Sell NowHigh

CRSP is entrenched in a Stage 4 decline with confirmed Support Failure and persistent lower highs/lower lows. Despite a long-term uptrend, medium- and short-term biases are decisively bearish, reinforced by down-sloping EMAs, distribution volume, and lack of exhaustion despite extreme oversold. Under the SPEC strategy, we take a Sell Now posture, selling into any rallies toward the EMA resistance zone.

  • FDA approval of Casgevy for sickle cell and β-thalassemia expands U.S. base by ~5,500 pediatric patients
  • Bank of America, HC Wainwright, Piper Sandler uphold buy ratings and $110 price target
  • Q2 2026 projected EPS of -$1.12 and revenue of $7.4 M indicate ongoing losses
Full analysis →
Insider Trades53 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
May 29, 2026SellCRSPNaimish PatelChief Medical Officer3,786$55.62$4.6B-39.12%+8.30%$210.6K-8.78%Sell Now
Mar 23, 2026SellCRSPJames R. KasingerGeneral Counsel and Secretary3,182$46.78$4.6B-39.12%+8.30%$148.9K-1.84%Sell Now
Mar 23, 2026SellCRSPRaju PrasadChief Financial Officer3,708$46.78$4.6B-39.12%+8.30%$173.5K-3.79%Sell Now
Mar 23, 2026SellCRSPSamarth KulkarniChief Executive Officer10,020$46.78$4.6B-39.12%+8.30%$468.7K-2.00%Sell Now
Mar 16, 2026SellCRSPNaimish PatelChief Medical Officer3,150$48.26$4.6B-39.12%+8.30%$152.0K-7.75%Sell Now
Mar 16, 2026SellCRSPJames R. KasingerGeneral Counsel and Secretary3,450$48.26$4.6B-39.12%+8.30%$166.5K-2.99%Sell Now
Mar 16, 2026SellCRSPRaju PrasadChief Financial Officer10,619$44.85$4.6B-39.12%+8.30%$476.3K-12.37%Sell Now
Mar 16, 2026SellCRSPSamarth KulkarniChief Executive Officer10,349$48.26$4.6B-39.12%+8.30%$499.4K-3.25%Sell Now
Mar 11, 2026SellCRSPJames R. KasingerGeneral Counsel and Secretary2,800$52.80$4.6B-39.12%+8.30%$147.8K-2.91%Sell Now
Mar 11, 2026SellCRSPSamarth KulkarniChief Executive Officer9,798$52.80$4.6B-39.12%+8.30%$517.3K-3.70%Sell Now
Feb 19, 2026SellCRSPJames R. KasingerGeneral Counsel and Secretary2,112$52.58$4.6B-39.12%+8.30%$111.0K-2.42%Sell Now
Feb 19, 2026SellCRSPSamarth KulkarniChief Executive Officer6,967$52.58$4.6B-39.12%+8.30%$366.3K-2.99%Sell Now
Jan 22, 2026SellCRSPRaju PrasadChief Financial Officer69,944$52.67$4.6B-39.12%+8.30%$3.7M+0.00%10b5-1Sell Now
Jan 20, 2026SellCRSPSamarth KulkarniChief Executive Officer90,000$57.40$4.6B-39.12%+8.30%$5.2M-14.49%10b5-1Sell Now
Jan 6, 2026SellCRSPRaju PrasadChief Financial Officer59,400$52.56$4.6B-39.12%+8.30%$3.1M+0.00%10b5-1Sell Now
Dec 22, 2025SellCRSPRaju PrasadChief Financial Officer10,000$55.95$4.6B-39.12%+8.30%$559.5K-26.47%10b5-1Sell Now
Dec 18, 2025SellCRSPSamarth KulkarniChief Executive Officer30,000$54.84$4.6B-39.12%+8.30%$1.6M-11.80%Sell Now
Oct 17, 2025SellCRSPSamarth KulkarniChief Executive Officer50,895$67.91$4.6B-39.12%+8.30%$3.5M-8.41%Sell Now
Oct 14, 2025SellCRSPJames R. KasingerGeneral Counsel and Secretary1,076$66.60$4.6B-39.12%+8.30%$71.7K-1.24%Sell Now
Oct 14, 2025SellCRSPSamarth KulkarniChief Executive Officer4,242$66.60$4.6B-39.12%+8.30%$282.5K-1.95%Sell Now
Sep 17, 2025SellCRSPSamarth KulkarniChief Executive Officer6,000$59.07$4.6B-39.12%+8.30%$354.4K-2.90%Sell Now
Aug 18, 2025SellCRSPSamarth KulkarniChief Executive Officer13,081$58.15$4.6B-39.12%+8.30%$760.7K-5.94%Sell Now
May 29, 2025SellCRSPNaimish PatelChief Medical Officer3,932$35.94$4.6B-39.12%+8.30%$141.3K-9.83%Sell Now
Apr 3, 2025BuyCRSPNaimish PatelChief Medical Officer1,508$32.96$4.6B-39.12%+8.30%$49.7KSell Now
Mar 21, 2025SellCRSPJulianne BrunoChief Operating Officer1,714$41.23$4.6B-39.12%+8.30%$70.7K-7.29%Sell Now
Mar 21, 2025SellCRSPRaju PrasadChief Financial Officer2,197$41.23$4.6B-39.12%+8.30%$90.6K-5.83%Sell Now
Mar 21, 2025SellCRSPJames R. KasingerGeneral Counsel and Secretary3,185$41.23$4.6B-39.12%+8.30%$131.3K-3.07%Sell Now
Mar 21, 2025SellCRSPSamarth KulkarniChief Executive Officer10,031$41.23$4.6B-39.12%+8.30%$413.6K-3.80%Sell Now
Mar 17, 2025SellCRSPRaju PrasadChief Financial Officer3,762$41.80$4.6B-39.12%+8.30%$157.3K-3.74%Sell Now
Mar 11, 2025SellCRSPJulianne BrunoChief Operating Officer1,388$42.54$4.6B-39.12%+8.30%$59.0K-6.05%Sell Now
Mar 11, 2025SellCRSPJames R. KasingerGeneral Counsel and Secretary3,966$42.67$4.6B-39.12%+8.30%$169.2K-2.32%Sell Now
Mar 11, 2025SellCRSPSamarth KulkarniChief Executive Officer14,435$42.70$4.6B-39.12%+8.30%$616.3K-3.44%Sell Now
Feb 19, 2025SellCRSPJulianne BrunoChief Operating Officer333$52.80$4.6B-39.12%+8.30%$17.6K-4.14%Sell Now
Feb 19, 2025SellCRSPSamarth KulkarniChief Executive Officer18,360$55.20$4.6B-39.12%+8.30%$1.0M-9.66%10b5-1Sell Now
Feb 18, 2025SellCRSPJames R. KasingerGeneral Counsel and Secretary11,542$53.67$4.6B-39.12%+8.30%$619.5K-7.07%Sell Now
Feb 18, 2025SellCRSPSamarth KulkarniChief Executive Officer18,568$54.21$4.6B-39.12%+8.30%$1.0M-4.43%10b5-1Sell Now
Dec 24, 2024BuyCRSPSamarth KulkarniChief Executive Officer13,751$16.21$4.6B-39.12%+8.30%$222.9K+7.57%Sell Now
Dec 2, 2024SellCRSPSamarth KulkarniChief Executive Officer15,000$55.10$4.6B-39.12%+8.30%$826.6K-7.63%10b5-1Sell Now
Nov 11, 2024SellCRSPSamarth KulkarniChief Executive Officer30,000$55.62$4.6B-39.12%+8.30%$1.7M-6.98%10b5-1Sell Now
Oct 14, 2024SellCRSPJames R. KasingerGeneral Counsel and Secretary1,089$46.28$4.6B-39.12%+8.30%$50.4K-1.60%Sell Now
Oct 14, 2024SellCRSPSamarth KulkarniChief Executive Officer4,293$46.28$4.6B-39.12%+8.30%$198.7K-1.73%Sell Now
Aug 8, 2024SellCRSPSamarth KulkarniChief Executive Officer100,000$47.86$4.6B-39.12%+8.30%$4.8M-31.01%Sell Now
Jun 21, 2024SellCRSPJulianne BrunoChief Operating Officer3,366$56.09$4.6B-39.12%+8.30%$188.8K-33.29%Sell Now
Apr 15, 2024SellCRSPSamarth KulkarniChief Executive Officer39,164$39.52$4.6B-39.12%+8.30%$1.5M+0.00%10b5-1Sell Now
Mar 15, 2024SellCRSPRaju PrasadChief Financial Officer3,524$72.69$4.6B-39.12%+8.30%$256.2K-8.81%Sell Now
Mar 15, 2024SellCRSPSamarth KulkarniChief Executive Officer40,000$45.80$4.6B-39.12%+8.30%$1.8M+0.00%10b5-1Sell Now
Mar 11, 2024SellCRSPJames R. KasingerGeneral Counsel and Secretary3,947$77.15$4.6B-39.12%+8.30%$304.5K-2.74%Sell Now
Mar 11, 2024SellCRSPSamarth KulkarniChief Executive Officer14,385$77.04$4.6B-39.12%+8.30%$1.1M-2.92%Sell Now
Feb 20, 2024SellCRSPJames R. KasingerGeneral Counsel and Secretary1,913$79.67$4.6B-39.12%+8.30%$152.4K-2.86%Sell Now
Feb 20, 2024SellCRSPSamarth KulkarniChief Executive Officer6,370$79.67$4.6B-39.12%+8.30%$507.5K-2.80%Sell Now
Feb 15, 2024SellCRSPSamarth KulkarniChief Executive Officer40,000$49.74$4.6B-39.12%+8.30%$2.0M+0.00%10b5-1Sell Now
Jan 29, 2024SellCRSPSamarth KulkarniChief Executive Officer100,000$39.82$4.6B-39.12%+8.30%$4.0M+0.00%10b5-1Sell Now
Jan 16, 2024SellCRSPSamarth KulkarniChief Executive Officer40,000$40.81$4.6B-39.12%+8.30%$1.6M+0.00%10b5-1Sell Now